Mizuho Securities has upgraded Palantir (NASDAQ:PLTR) from Underperform to Neutral after the company's revenue growth ...

Palantir Technologies (PLTR) has recently forged partnerships with Knightscope Inc. for entry into the U.S. federal marketplace and with Velocity Clinical Research to enhance clinical trial efficiency ...

Felix Wintle, manager of the VT Tyndall North American Fund, highlights three favourite US stocks where he'd put his money ...

Palantir stock on Thursday hit an all-time high ahead of its second quarter earnings report on Aug. 4. Palantir has advanced ...

Goldman Sachs projects a 50% surge in global datacenter demand by 2027 as Meta, Palantir and Amazon ramp up AI infrastructure ...

With a strong brand and a mover advantage, the company seems positioned to benefit from the broader AI wave. However, beneath ...

Reconciling invoices and payments in clinical research has long been a fragmented, time-consuming, and error-prone task. Sites often use multiple siloed systems to manage invoices, while Sponsors and ...

Key Points Palantir is the biggest gainer in the S&P 500 so far this year. The AI-driven software company’s earnings are ...

Symbotic's technology automates the processing of pallets and cases. Its fully autonomous mobile robots, called Symbots, move ...

Mizuho Securities upgraded their rating on Palantir's stock from underperform to neutral due to the company's surge in ...

Palantir (NASDAQ: PLTR) continues to dazzle the market, breaching the $150 mark as its growth sprints ahead. Investors are ...

Excitement surrounding AI software and strong quarterly results helped power big gains for Palantir stock in this year's ...